World's Best Scientists 2026 revealed!
Silvia Deaglio

Silvia Deaglio

D-Index & Metrics

Biology and Biochemistry

D-Index
73
Citations
20600
World Ranking
5899
National Ranking
134

Overview

Silvia Deaglio is affiliated with the University of Turin in Italy and has a research profile spanning medicine and biochemistry, genetics, and molecular biology. Their work emphasizes molecular biology, genetics, immunology, surgery, and cardiology and cardiovascular medicine. The scientific contributions focus significantly on chronic lymphocytic leukemia, renal transplantation, lymphoma, cancer genomics, renal cancers, genetic kidney diseases, and immune cell function.

Their recent publications include studies such as "NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation" (2020) published in Frontiers in Oncology, "Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions" (2020) from the International Journal of Molecular Sciences, and "HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity" (2020) published in Transplantation. Additional recent works include "ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models" (2021) from Blood and "Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer" (2020) in Cancers.

Frequently collaborating scientists include Tiziana Vaisitti, Antonio Amoroso, Francesca Arruga, Valeria Bracciamà, and Licia Peruzzi.

Major publication venues where this researcher has published multiple papers include:

  • Blood
  • European Heart Journal Supplements
  • Nephrology Dialysis Transplantation
  • International Journal of Molecular Sciences
  • Frontiers in Oncology

The main fields of study for Silvia Deaglio are:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their research subfields cover:

  • Molecular Biology
  • Genetics
  • Immunology
  • Surgery
  • Cardiology and Cardiovascular Medicine

Silvia Deaglio's work addresses key research topics including:

  • Chronic Lymphocytic Leukemia Research
  • Renal Transplantation Outcomes and Treatments
  • Lymphoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Renal and related cancers
  • Genetic and Kidney Cyst Diseases
  • Immune Cell Function and Interaction

Best Publications

  • Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

    Silvia Deaglio;Karen M. Dwyer;Wenda Gao;David J Friedman

  • Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology

    Fabio Malavasi;Silvia Deaglio;Ada Funaro;Enza Ferrero

  • Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

    Davide Rossi;Silvia Rasi;Giulia Fabbri;Valeria Spina

  • Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

    Davide Rossi;Alessio Bruscaggin;Valeria Spina;Silvia Rasi

  • Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member

    Silvia Deaglio;Massimo Morra;Roberto Mallone;Clara M. Ausiello

  • The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development

    Davide Rossi;Vladimir Trifonov;Marco Fangazio;Alessio Bruscaggin

  • Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia

    Davide Rossi;Marco Fangazio;Silvia Rasi;Tiziana Vaisitti

  • Human CD38: a (r)evolutionary story of enzymes and receptors.

    Silvia Deaglio;Kapil Mehta;Fabio Malavasi

  • CD39 and control of cellular immune responses

    Karen M. Dwyer;Silvia Deaglio;Wenda Gao;David J. Friedman

  • Ectonucleotidases as Regulators of Purinergic Signaling in Thrombosis, Inflammation, and Immunity

    Silvia Deaglio;Simon C. Robson

  • CD38 and chronic lymphocytic leukemia: a decade later

    Fabio Malavasi;Silvia Deaglio;Rajendra Damle;Giovanna Cutrona

  • The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia

    Davide Brusa;Sara Serra;Marta Coscia;Davide Rossi

  • CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

    Silvia Deaglio;Tiziana Vaisitti;Luciana Bergui;Lisa Bonello

  • Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

    Davide Rossi;Valeria Spina;Michaela Cerri;Silvia Rasi

  • CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.

    Silvia Deaglio;Andrea Capobianco;Luciana Bergui;Jan Dürig

  • Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype

    Karen M. Dwyer;Dusan Hanidziar;Prabhakar Putheti;Prue A Hill

  • CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential

    Silvia Deaglio;Tiziana Vaisitti;Semra Aydin;Luciana Bergui

  • Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.

    Davide Rossi;Silvia Deaglio;David Dominguez-Sola;Silvia Rasi

  • TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway.

    Alessia Calzolari;Carla Raggi;Silvia Deaglio;Nadia Maria Sposi

  • Transferrin receptor 2 is frequently expressed in human cancer cell lines.

    Alessia Calzolari;Isabella Oliviero;Silvia Deaglio;Gualtiero Mariani

Frequent Co-Authors

Fabio Malavasi
Fabio Malavasi University of Turin
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Davide Rossi
Davide Rossi European Society for Medical Oncology
Luca Laurenti
Luca Laurenti Catholic University of the Sacred Heart
Valter Gattei
Valter Gattei University of Trieste
Giorgio Inghirami
Giorgio Inghirami Cornell University
Francesco Bertoni
Francesco Bertoni Institute of Oncology Research
Richard R. Furman
Richard R. Furman NewYork–Presbyterian Hospital
Claudio Tripodo
Claudio Tripodo FIRC Institute of Molecular Oncology
Simon C. Robson
Simon C. Robson Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can open doors to a range of dynamic careers related to Biology and Biochemistry. Many students seek flexible options, with the convenience to fast-track their studies and enter the workforce sooner. Accelerated programs—such as an accelerated kinesiology degree online—offer a strong foundation in human movement and physiology, providing a complementary path for those interested in health sciences.

Healthcare professionals looking to specialize can benefit from swift certificate programs. For example, the shortest online pmhnp certificate programs allow nurses to expand into psychiatric-mental health rapidly, while the shortest post master's fnp program supports those aiming to become family nurse practitioners at an accelerated pace.

Nutrition remains a strong career choice for biology or biochemistry graduates. Enrolling in an accelerated nutrition degree online provides a cost-effective pathway to qualify as a nutrition or dietetics professional.

By considering these online degree and certificate options, students can tailor their educational journey to a wide variety of science and healthcare-related careers.

Best Scientists Citing Silvia Deaglio

Trending Scientists